Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Multiple Sclerosis

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 7 articles:
HTML format



Single Articles


    May 2026
  1. GIOVANNONI G, Airas L, Bove R, Cutter GR, et al
    Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis, including older patients and those with more advanced disease (ORATORIO-HAND): a multicentre, double-blind, randomised, placebo-controlled, phase 3b study.
    Lancet. 2026;407:2195-2207.
    PubMed     Abstract available


  2. HAUSER SL, Giovannoni G, Montalban X, Oh J, et al
    Efficacy and safety of a bodyweight-adjusted higher dose of ocrelizumab in relapsing (MUSETTE) and primary progressive (GAVOTTE) multiple sclerosis: two multicentre, randomised, double-blind, parallel-group phase 3b trials.
    Lancet. 2026;407:2180-2194.
    PubMed     Abstract available


  3. SAMARASEKERA U
    Stephen Hauser: transforming treatment for multiple sclerosis.
    Lancet. 2026;407:2163.
    PubMed    


  4. COCCO E
    Integrating peripheral immune control and brain health in the multiple sclerosis continuum.
    Lancet. 2026;407:2144-2146.
    PubMed    


    October 2025
  5. FILIPPI M, Rocca MA
    MS-STAT2: lessons from negative trials in multiple sclerosis.
    Lancet. 2025 Oct 1:S0140-6736(25)01673-3. doi: 10.1016/S0140-6736(25)01673.
    PubMed    


  6. CHATAWAY J, Williams T, Blackstone J, John N, et al
    Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial.
    Lancet. 2025 Oct 1:S0140-6736(25)01039-6. doi: 10.1016/S0140-6736(25)01039.
    PubMed     Abstract available


    November 2023
  7. JAKIMOVSKI D, Bittner S, Zivadinov R, Morrow SA, et al
    Multiple sclerosis.
    Lancet. 2023 Nov 7:S0140-6736(23)01473-3. doi: 10.1016/S0140-6736(23)01473.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum